Wednesday, July 15, 2009

Wyeth's Prevenar 13* Receives First Approval

Wyeth Pharmaceuticals, a division of Wyeth, announced today that the Chilean Ministry of Health, MINSAL (Ministerio de Salud), has become the first government agency to approve Prevenar 13* Valent, (Pneumococcal Conjugate Vaccine 13 Valent (Diphtheria CRM(197) Protein)) for infants and young children.

The details can be read here.

No comments: